PharmGen Science, Inc.
004720 | KO
Overview
Corporate Details
- ISIN(s):
- KR7004720009
- LEI:
- Country:
- South Korea
- Address:
- 경기 화성시 향남면 상신리 향남제약공단 902-5, 화성시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-19 00:00 |
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-12 00:00 |
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
|
Korean | 15.9 KB | ||
| 2025-06-12 00:00 |
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
|
Korean | 14.0 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.8 MB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.9 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.9 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.0 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 110.0 KB | ||
| 2025-04-11 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 14.4 KB | ||
| 2025-04-10 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 677.5 KB | ||
| 2025-04-03 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-04-03 00:00 |
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 34.9 KB | ||
| 2025-03-31 00:00 |
AGM Information
정기주주총회결과
|
Korean | 28.6 KB |
Automate Your Workflow. Get a real-time feed of all PharmGen Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for PharmGen Science, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmGen Science, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
United Kingdom
4BB
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
United States of America
FDMT
Germany
VSC
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
United States of America
SXTP
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
United States of America
ETNB
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
United States of America
AARD
Develops medical devices, diagnostics, nutritionals, and pharmaceuticals for global health.
United States of America
ABT
United States of America
ABT
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
United States of America
ABBV
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
United States of America
ABCL